Back to Search
Start Over
Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Aug2016 Supplement, Vol. 16, pS74-S81, 1p
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 16
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 117336249
- Full Text :
- https://doi.org/10.1016/j.clml.2016.02.013